Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Drug Policy Governance in the UK: lessons from changes to and debates concerning the classification of cannabis under the 1971 Misuse of Drugs Act.

Monaghan M.

Int J Drug Policy. 2014 Sep;25(5):1025-30. doi: 10.1016/j.drugpo.2014.02.001. Epub 2014 Feb 14.

PMID:
24635973
2.

What is good governance in the context of drug policy?

Singleton N, Rubin J.

Int J Drug Policy. 2014 Sep;25(5):935-41. doi: 10.1016/j.drugpo.2014.03.008. Epub 2014 Mar 30.

PMID:
24768218
3.

Making drug policy together: reflections on evidence, engagement and participation.

Roberts M.

Int J Drug Policy. 2014 Sep;25(5):952-6. doi: 10.1016/j.drugpo.2014.04.014. Epub 2014 Apr 29.

PMID:
24882708
4.

How ideology shapes the evidence and the policy: what do we know about cannabis use and what should we do?

Macleod J, Hickman M.

Addiction. 2010 Aug;105(8):1326-30. doi: 10.1111/j.1360-0443.2009.02846.x. Epub 2010 Feb 9.

PMID:
20148792
5.

Is UK drug policy evidence based?

Bennett T, Holloway K.

Int J Drug Policy. 2010 Sep;21(5):411-7. doi: 10.1016/j.drugpo.2010.02.004. Epub 2010 Mar 26.

PMID:
20347288
6.

Towards good governance in drug policy: evidence, stakeholders and politics.

MacGregor S, Singleton N, Trautmann F.

Int J Drug Policy. 2014 Sep;25(5):931-4. doi: 10.1016/j.drugpo.2014.06.017. Epub 2014 Jul 11. No abstract available. Erratum in: Int J Drug Policy. 2014 Nov;25(6):1151.

PMID:
25086908
7.

Drug policy reform and the reclassification of cannabis in England and Wales: A cautionary tale.

Shiner M.

Int J Drug Policy. 2015 Jul;26(7):696-704. doi: 10.1016/j.drugpo.2015.03.009. Epub 2015 Apr 8.

PMID:
25959525
8.

The latest buzz on medicinal marijuana: a legal and medical perspective.

Steinborn JJ, Chinn AK, Carter GT.

Am J Hosp Palliat Care. 2001 Sep-Oct;18(5):295, 298. No abstract available.

PMID:
11565181
9.

How do drug policy makers access research evidence?

Ritter A.

Int J Drug Policy. 2009 Jan;20(1):70-5. doi: 10.1016/j.drugpo.2007.11.017. Epub 2008 Jan 15.

PMID:
18226519
10.

Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model.

Lenton S, Frank VA, Barratt MJ, Dahl HV, Potter GR.

Int J Drug Policy. 2015 Mar;26(3):257-66. doi: 10.1016/j.drugpo.2014.08.002. Epub 2014 Aug 18.

PMID:
25181993
11.

Governance in EU illicit drugs policy.

Edwards C, Galla M.

Int J Drug Policy. 2014 Sep;25(5):942-7. doi: 10.1016/j.drugpo.2014.04.009. Epub 2014 Apr 23.

PMID:
25060612
12.
13.

Politics of hard and soft drugs.

Dean M.

Lancet. 1995 Nov 11;346(8985):1285. No abstract available.

PMID:
7475725
14.

The challenges in developing a rational cannabis policy.

Hall W, Lynskey M.

Curr Opin Psychiatry. 2009 May;22(3):258-62. doi: 10.1097/YCO.0b013e3283298f36. Review.

PMID:
19293714
15.

Additional considerations.

Nadelmann E, Gutwillig S, Davies J.

Addiction. 2012 May;107(5):873-5. doi: 10.1111/j.1360-0443.2011.03695.x. No abstract available.

PMID:
22471566
16.
17.

Public health issue brief: medical marijuana: year end report-2004.

Varma P.

Issue Brief Health Policy Track Serv. 2004 Dec 31:1-9.

PMID:
15765574
18.

What would an evidence based drug policy be like?

Singleton N, Strang J.

BMJ. 2014 Dec 9;349:g7493. doi: 10.1136/bmj.g7493. No abstract available.

PMID:
25492041
19.

Blurred boundaries: the therapeutics and politics of medical marijuana.

Bostwick JM.

Mayo Clin Proc. 2012 Feb;87(2):172-86. doi: 10.1016/j.mayocp.2011.10.003. Review.

20.

Cannabis policy: issues and options.

Abel S, Casswell S.

N Z Med J. 1998 Sep 25;111(1074):367-70.

PMID:
11039824
Items per page

Supplemental Content

Write to the Help Desk